A newly patented technology developed as a collaboration in the
departments of Biomedical Engineering, Orthopaedics, and
Microbiology and Immunology is at the heart of an Office of Naval
Research (ONR) grant focused on preventing and treating orthopaedic
A global study led by Paresh Dandona, MD, PhD, found a majority
of patients with Type 1 diabetes who were treated with
dapagliflozin, a Type 2 diabetes medicine, had a significant
decline in their blood sugar levels.